Mark W. Irvine

984 total citations
22 papers, 802 citations indexed

About

Mark W. Irvine is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Mark W. Irvine has authored 22 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 16 papers in Molecular Biology and 9 papers in Cognitive Neuroscience. Recurrent topics in Mark W. Irvine's work include Neuroscience and Neuropharmacology Research (19 papers), Receptor Mechanisms and Signaling (10 papers) and Memory and Neural Mechanisms (9 papers). Mark W. Irvine is often cited by papers focused on Neuroscience and Neuropharmacology Research (19 papers), Receptor Mechanisms and Signaling (10 papers) and Memory and Neural Mechanisms (9 papers). Mark W. Irvine collaborates with scholars based in United Kingdom, United States and Canada. Mark W. Irvine's co-authors include David E. Jane, Daniel T. Monaghan, Guangyu Fang, Graham L. Collingridge, Arturas Volianskis, Neil Bannister, Erica S. Burnell, Zuner A. Bortolotto, Kiran Sapkota and Elek Molnár and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Physiology.

In The Last Decade

Mark W. Irvine

22 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark W. Irvine United Kingdom	15	556	458	157	73	62	22	802
Kenneth M. Johnson United States	14	653 1.2×	414 0.9×	122 0.8×	80 1.1×	60 1.0×	16	931
Vojtěch Vyklický Czechia	17	628 1.1×	489 1.1×	59 0.4×	58 0.8×	76 1.2×	30	950
Wei Lemaire United States	16	881 1.6×	784 1.7×	189 1.2×	122 1.7×	91 1.5×	25	1.2k
Shujia Zhu China	17	763 1.4×	690 1.5×	114 0.7×	42 0.6×	125 2.0×	38	1.2k
Feng Yi United States	15	844 1.5×	611 1.3×	193 1.2×	44 0.6×	87 1.4×	32	1.2k
Laétitia Mony France	14	832 1.5×	749 1.6×	73 0.5×	96 1.3×	83 1.3×	23	1.2k
Ann Marie L. Ogden United States	13	568 1.0×	429 0.9×	166 1.1×	121 1.7×	39 0.6×	17	846
Sylvie Chaboz Switzerland	9	1.1k 1.9×	692 1.5×	104 0.7×	46 0.6×	112 1.8×	9	1.5k
David R. Helton United States	14	831 1.5×	614 1.3×	207 1.3×	112 1.5×	79 1.3×	22	1.1k
Hirohiko Hikichi Japan	16	503 0.9×	453 1.0×	108 0.7×	127 1.7×	42 0.7×	31	747

Countries citing papers authored by Mark W. Irvine

Since Specialization

Citations

This map shows the geographic impact of Mark W. Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Irvine more than expected).

Fields of papers citing papers by Mark W. Irvine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Irvine. The network helps show where Mark W. Irvine may publish in the future.

Co-authorship network of co-authors of Mark W. Irvine

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Irvine. A scholar is included among the top collaborators of Mark W. Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Irvine. Mark W. Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sapkota, Kiran, Erica S. Burnell, Mark W. Irvine, et al.. (2021). Pharmacological characterization of a novel negative allosteric modulator of NMDA receptors, UBP792. Neuropharmacology. 201. 108818–108818. 3 indexed citations

Bannister, Neil, Mark W. Irvine, Erica S. Burnell, et al.. (2021). Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators. Neuropharmacology. 202. 108840–108840. 17 indexed citations

Irvine, Mark W., Erica S. Burnell, Kiran Sapkota, et al.. (2020). Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors. Nature Communications. 11(1). 423–423. 25 indexed citations

Irvine, Mark W., Guangyu Fang, Kiran Sapkota, et al.. (2018). Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid. European Journal of Medicinal Chemistry. 164. 471–498. 11 indexed citations

Sapkota, Kiran, Kim Doré, Kang Tang, et al.. (2018). The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators. Biochemical Pharmacology. 159. 140–153. 18 indexed citations

Erotocritou, M, Timo Greiner, Remigijus Lapė, et al.. (2017). The Startle Disease Mutation E103K Impairs Activation of Human Homomeric α1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site. Journal of Biological Chemistry. 292(12). 5031–5042. 9 indexed citations

Sapkota, Kiran, Mark W. Irvine, Guangyu Fang, et al.. (2017). Mechanism and properties of positive allosteric modulation of N -methyl- d -aspartate receptors by 6-alkyl 2-naphthoic acid derivatives. Neuropharmacology. 125. 64–79. 16 indexed citations

Sapkota, Kiran, Mark W. Irvine, Guangyu Fang, et al.. (2017). A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors. Scientific Reports. 7(1). 6933–6933. 8 indexed citations

Burnell, Erica S., Mark W. Irvine, Daniel T. Monaghan, et al.. (2016). Multiple roles of GluN2B-containing NMDA receptors in synaptic plasticity in juvenile hippocampus. Neuropharmacology. 112(Pt A). 76–83. 36 indexed citations

10.

Irvine, Mark W., et al.. (2015). An interchangeable role for kainate and metabotropic glutamate receptors in the induction of rat hippocampal mossy fiber long‐term potentiation in vivo. Hippocampus. 25(11). 1407–1417. 7 indexed citations

11.

Monaghan, Daniel T., et al.. (2012). Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators. Neurochemistry International. 61(4). 581–592. 75 indexed citations

12.

Volianskis, Arturas, Neil Bannister, Valerie J. Collett, et al.. (2012). Different NMDA receptor subtypes mediate induction of long‐term potentiation and two forms of short‐term potentiation at CA1 synapses in rat hippocampusin vitro. The Journal of Physiology. 591(4). 955–972. 73 indexed citations

13.

Collingridge, Graham L., Arturas Volianskis, Neil Bannister, et al.. (2012). The NMDA receptor as a target for cognitive enhancement. Neuropharmacology. 64. 13–26. 188 indexed citations

14.

Irvine, Mark W., Arturas Volianskis, Guangyu Fang, et al.. (2012). Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-d-aspartate receptors. Neurochemistry International. 61(4). 593–600. 36 indexed citations

15.

Irvine, Mark W., Daniel Dlaboga, Richard P. Hulse, et al.. (2011). Piperazine-2,3-dicarboxylic Acid Derivatives as Dual Antagonists of NMDA and GluK1-Containing Kainate Receptors. Journal of Medicinal Chemistry. 55(1). 327–341. 19 indexed citations

16.

Irvine, Mark W., et al.. (2011). Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid. Neuropharmacology. 62(4). 1730–1736. 28 indexed citations

17.

Irvine, Mark W., et al.. (2010). A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors. Journal of Pharmacology and Experimental Therapeutics. 335(3). 614–621. 76 indexed citations

18.

Irvine, Mark W., et al.. (2009). NMDA receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives; preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. Bristol Research (University of Bristol). 331. 618–626. 1 indexed citations

19.

Feng, Bihua, Timur Tsintsadze, Richard H. Morley, et al.. (2009). N-Methyl-d-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse. Journal of Pharmacology and Experimental Therapeutics. 331(2). 618–626. 46 indexed citations

20.

Irvine, Mark W., et al.. (2008). Rhodanine derivatives as novel inhibitors of PDE4. Bioorganic & Medicinal Chemistry Letters. 18(6). 2032–2037. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact